Literature DB >> 10920733

Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 1: Thiazide diuretics.

J M Wright1.   

Abstract

Elevated blood pressure is associated with an increased risk of cardiovascular illness and death. Efforts to reduce that risk have led to recommendations for a wide array of nondrug and drug therapies. Choosing the optimal first-line drug for hypertensive patients should address a hierarchy of treatment goals: decrease in morbidity and mortality associated with hypertension, decrease in blood pressure, lack of effect on patients' quality of life, dosing convenience and low cost. This article examines the evidence for thiazide diuretics as a class of first-line antihypertensive drugs in light of these treatment goals. The evidence indicates that low-dose thiazides are preferable to high-dose thiazides and that low-dose thiazides are better than or equivalent to other antihypertensive drugs for each of the goals of therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10920733      PMCID: PMC1232554     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  7 in total

Review 1.  Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?

Authors:  J M Wright; C H Lee; G K Chambers
Journal:  CMAJ       Date:  1999-07-13       Impact factor: 8.262

2.  Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.

Authors:  T Philipp; M Anlauf; A Distler; H Holzgreve; J Michaelis; S Wellek
Journal:  BMJ       Date:  1997-07-19

3.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

Authors:  B M Psaty; N L Smith; D S Siscovick; T D Koepsell; N S Weiss; S R Heckbert; R N Lemaitre; E H Wagner; C D Furberg
Journal:  JAMA       Date:  1997-03-05       Impact factor: 56.272

4.  Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.

Authors:  R E Schmieder; P Martus; A Klingbeil
Journal:  JAMA       Date:  1996-05-15       Impact factor: 56.272

5.  Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

Authors:  J D Curb; S L Pressel; J A Cutler; P J Savage; W B Applegate; H Black; G Camel; B R Davis; P H Frost; N Gonzalez; G Guthrie; A Oberman; G H Rutan; J Stamler
Journal:  JAMA       Date:  1996-12-18       Impact factor: 56.272

6.  Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.

Authors:  J D Neaton; R H Grimm; R J Prineas; J Stamler; G A Grandits; P J Elmer; J A Cutler; J M Flack; J A Schoenberger; R McDonald
Journal:  JAMA       Date:  1993-08-11       Impact factor: 56.272

7.  Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  B J Materson; D J Reda; W C Cushman; B M Massie; E D Freis; M S Kochar; R J Hamburger; C Fye; R Lakshman; J Gottdiener
Journal:  N Engl J Med       Date:  1993-04-01       Impact factor: 91.245

  7 in total
  13 in total

Review 1.  Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence?

Authors:  K A Payne; S Esmonde-White
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

2.  The value of industry-sponsored studies of initial antihypertensive therapies.

Authors:  J J Caro; K Payne
Journal:  CMAJ       Date:  2001-06-26       Impact factor: 8.262

3.  Statistics and drug utilization: are prescribing rates really that high?

Authors:  S Morgan
Journal:  CMAJ       Date:  2001-11-27       Impact factor: 8.262

4.  First-line drugs for hypertension.

Authors:  J D Spence
Journal:  CMAJ       Date:  2001-01-23       Impact factor: 8.262

Review 5.  What are the elements of good treatment for hypertension?

Authors:  C D Mulrow; M Pignone
Journal:  BMJ       Date:  2001-05-05

Review 6.  Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 2: Beta-blockers.

Authors:  J M Wright
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

7.  Quantifying components of drug expenditure inflation: the British Columbia seniors' drug benefit plan.

Authors:  Steven G Morgan
Journal:  Health Serv Res       Date:  2002-10       Impact factor: 3.402

Review 8.  Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 3: Angiotensin-converting-enzyme inhibitors.

Authors:  J M Wright
Journal:  CMAJ       Date:  2000-08-08       Impact factor: 8.262

Review 9.  Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.

Authors:  Ezequiel Balmori Melian; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Indapamide-induced hyperparathyroidism: a case report.

Authors:  Miguel Debono; Ritwik Banerjee
Journal:  Eur J Clin Pharmacol       Date:  2007-06-05       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.